|
Re: Reverse Split, the good, bad and in between....
|
2
|
Resverlogix Corp.
|
Aug 14, 2018 10:25PM
|
|
Re: New Insider filing dated Feb 12 - Change in the nature of ownership
|
2
|
Resverlogix Corp.
|
Feb 16, 2020 07:23PM
|
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
1
|
Resverlogix Corp.
|
Sep 25, 2015 10:31AM
|
|
Re: Filled!
|
1
|
Zenith Epigenetics
|
Jan 21, 2021 10:29PM
|
|
Re: FDA
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 02:19PM
|
|
Re: Choosing Between Two License Deals
|
1
|
Resverlogix Corp.
|
Sep 26, 2016 03:59PM
|
|
Re: How come?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 28, 2020 06:29PM
|
|
Re: RVX TO HOST R&D UPDATE FEATURING KEY OPINION LEADERS IN CVD AND RENAL DISEASE
|
1
|
Resverlogix Corp.
|
Oct 04, 2016 07:04PM
|
|
Re: Renal trial delayed (again)
|
1
|
Resverlogix Corp.
|
Sep 30, 2017 02:23PM
|
|
Resverlogix ad
|
1
|
Resverlogix Corp.
|
Jan 29, 2021 01:15PM
|
|
Re: ... has anybody received
|
1
|
Resverlogix Corp.
|
Nov 28, 2016 03:03PM
|
|
Re: A couple of things....
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 08:41PM
|
|
Re: A Shenzhen Hepalink M&A type deal...
|
1
|
Resverlogix Corp.
|
Jan 06, 2018 06:05PM
|
|
Re: How come?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 27, 2020 12:14PM
|
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
1
|
Zenith Epigenetics
|
Sep 22, 2020 03:03PM
|
|
Share value
|
1
|
Zenith Epigenetics
|
Nov 22, 2017 04:14PM
|
|
Re: BIO-Europe Presentation is up
|
1
|
Resverlogix Corp.
|
Nov 07, 2017 12:29PM
|
|
Re: Timelines for notice of meeting for AGMs
|
1
|
Resverlogix Corp.
|
Sep 14, 2016 09:22PM
|
|
Re: Lots more options exercises reported at canadianinsider.com
|
1
|
Resverlogix Corp.
|
Jun 26, 2019 10:57PM
|
|
Re: Does anyone know the record date for incentive stock options?
|
1
|
Resverlogix Corp.
|
Sep 29, 2016 08:51PM
|
